Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Amortizatization of Intangibles: 2014-2024

Historic Amortizatization of Intangibles for Ptc Therapeutics (PTCT) over the last 11 years, with Dec 2024 value amounting to $12.5 million.

  • Ptc Therapeutics' Amortizatization of Intangibles rose 106.60% to $6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.6 million, marking a year-over-year increase of 33.88%. This contributed to the annual value of $12.5 million for FY2024, which is 27.50% up from last year.
  • According to the latest figures from FY2024, Ptc Therapeutics' Amortizatization of Intangibles is $12.5 million, which was up 27.50% from $9.8 million recorded in FY2023.
  • In the past 5 years, Ptc Therapeutics' Amortizatization of Intangibles registered a high of $41.4 million during FY2020, and its lowest value of $7.4 million during FY2021.
  • Its 3-year average for Amortizatization of Intangibles is $10.7 million, with a median of $9.9 million in 2022.
  • As far as peak fluctuations go, Ptc Therapeutics' Amortizatization of Intangibles spiked by 1,015.72% in 2020, and later crashed by 82.15% in 2021.
  • Yearly analysis of 5 years shows Ptc Therapeutics' Amortizatization of Intangibles stood at $41.4 million in 2020, then crashed by 82.15% to $7.4 million in 2021, then surged by 33.82% to $9.9 million in 2022, then declined by 0.58% to $9.8 million in 2023, then increased by 27.50% to $12.5 million in 2024.